Zadenvi^®

Zadenvi® contains denosumab, a protein (monoclonal antibody) that interferes with the action of another protein, in order to treat bone loss and osteoporosis. Treatment with denosumab makes bone stronger and less likely to break.

Zadenvi® is used to treat:

– Osteoporosis in women after the menopause (postmenopausal) and men who have an increased risk of fracture (broken bones), reducing the risk of spinal, nonspinal and hip fractures.

– Bone loss that results from a reduction in hormone (testosterone) level caused by surgery or treatment with medicines in patients with prostate cancer.

– Bone loss that results from long-term treatment with glucocorticoids in patients who have an increased risk of fracture.